Metal Hip Implants Receive Further FDA Review


The Food and Drug Administration (FDA) will hold a two-day meeting in June to discuss the mounting safety concerns about metal-on-metal hip implants, which increasing evidence indicates are more likely to fail than traditional plastic hip replacements.

On June 27-28, the FDA will gather input from scientists, researchers, patients and physicians to help regulators decide whether to impose new testing standards for all-metal hip implants. The FDA has already asked manufacturers of metal-on-metal hip implants to conduct additional follow-up studies regarding the safety and effectiveness of these potentially defective medical devices.

All-metal hip joints have faced scrutiny in recent years due to increasing reports of pain, swelling and device failure. Studies have indicated that metal-on-metal implants fail at a higher rate than plastic implants, and that patients who receive all-metal hip implants show increased concentrations of metal ions in their blood.

According to a March 29 Reuters article on the matter, about 270,000 hip replacement surgeries are performed each year in the United States. In the past few years, hundreds of thousands of hip implant devices has been recalled; Johnson & Johnson recalled more than 90,000 metal hip implants in 2010 alone.

Major hip implant recalls in recent years include:

If you received a metal-on-metal hip implant and later experienced complications, an experienced product liability attorney may be able to help you recover financial compensation for medical expenses, lost income, and pain and suffering.

Please contact to locate a qualified product liability lawyer near you.